For a deeper look at what GLP-1 approval actually required, Meto's clinical overview of GLP-1 drugs provides useful context as does our recent piece on Foundayo (orforglipron), the first oral GLP-1 to reach approval
Balata M, Becher MU (2024) Impact of semaglutide on weight and functional outcomes among obese heart failure patients: a propensity scores matching analysis
Level B Criteria (*): Requires at least one of ABX, or FMT, to be Yes
FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
Reports that look like they were created in a word processor, with inconsistent fonts, missing accreditation information, or stock photos of laboratory equipment, are almost certainly fabricated